Zacks Investment Research on MSN1d
PODD Stock to Gain From Favorable RADIANT Trial Results for Omnipod 5Insulet Corporation PODD announced favorable RADIANT trial clinical data for its Omnipod 5 at the 18th International Conference on Advanced Technologies and Treatments for Diabetes (“ATTD”). Omnipod 5 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback